Premium
Expression of the tumor‐associated mucin MUCI in an ovarian tumor cell line
Author(s) -
Stern Linda,
Palatsides Manuela,
De Kretser Theonne,
Ford Miriam
Publication year - 1992
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910500520
Subject(s) - mucin , biology , exon , complementary dna , microbiology and biotechnology , intron , nucleic acid sequence , rna splicing , glycoprotein , alternative splicing , ovarian tumor , messenger rna , gene , genetics , ovarian cancer , rna , biochemistry , cancer
Epithelial sialomucins constitute a family of high‐molecular‐weight glycoproteins associated with epithelial cell surfaces. Aberrant expression of these molecules has been observed in certain types of human epithelial tumors. Members of the MUCI family of mucins isolated from different tissue types have been shown to differ in biochemical properties and in immunological reactivity. The polymerase chain reaction (PCR) has been used in a study of the MUCI mRNA expressed in ovarian tumor cells. The intron/exon structure of the ovarian mucin gene has been examined, the nucleotide sequence of regions of the cDNA 5' and 3' to a central highly repetitive region of the molecule determined and genomic clones for this mucin from the ovarian tumor cell line COLO316 have been isolated and analyzed. The results are compared with the nucleotide sequence data obtained by others for MUCI cDNA in breast and pancreatic cell lines. With a single nucleotide exception, the splicing pattern and nucleotide sequence obtained from MUCI mRNA in the ovarian cell line is the same as that of the mRNA found in breast and pancreatic cell lines. However, it appears that the use of alternate splice acceptors for intron I in the ovarian cell line studied here is independent of the specific sequence variation thought to determine splicing of MUCI in breast tumor cells.